Literature DB >> 8133501

Attitudes of neurologists, psychiatrists, and psychotherapists towards predictive testing for Huntington's disease in Germany.

U Thies1, B Bockel, V Bochdalofsky.   

Abstract

Predictive testing for Huntington's disease (HD) in Germany is performed by genetic counsellors, neurologists, psychiatrists, and psychotherapists. In order to evaluate the attitudes of neurologists, psychiatrists, and psychotherapists in Germany towards predictive testing for HD, a postal questionnaire was sent to this group. Two German Bundesländer were chosen, Baden Württemberg (BW) and Niedersachsen (NS). Of 469 persons interviewed the response rate was 32.6%. The questionnaire consisted of 17 items assessing sociodemographic data, acquaintance with HD patients, lay organisations, attitudes towards genetic counselling, presymptomatic and prenatal DNA testing, and reproduction of persons at risk for HD. More than 70% of the subjects were well informed about predictive DNA testing but knowledge about the details of the test procedure, especially the World Federation of Neurology (WFN) and International Huntington Association (IHA)1 recommendations, was quite low (11.8%). Nevertheless, the majority would recommend predictive testing for HD although they anticipated problems for the probands. The majority of our respondents favoured psychological test and post-test counselling for those tested. Concerning reproduction, most subjects favoured prenatal testing or that persons at risk should refrain from having children. We found that the opinions of practitioners and at risk persons differed with respect to the predictive DNA test and, particularly, to prenatal testing. Therefore the testing procedure could be improved if practitioners were better informed about the DNA test in general and about the attitudes and wishes of their patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133501      PMCID: PMC1016638          DOI: 10.1136/jmg.30.12.1023

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  15 in total

1.  Uptake of presymptomatic predictive testing for Huntington's disease.

Authors:  D Craufurd; A Dodge; L Kerzin-Storrar; R Harris
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

2.  Understanding the decision to take the predictive test for Huntington disease.

Authors:  G J Meissen; C A Mastromauro; D K Kiely; D S McNamara; R H Myers
Journal:  Am J Med Genet       Date:  1991-06-15

3.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

4.  Attitudes of general practitioners to presymptomatic testing for Huntington's disease.

Authors:  M E Mennie; S M Holloway; D J Brock
Journal:  J Med Genet       Date:  1990-04       Impact factor: 6.318

5.  Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.

Authors:  M Huggins; M Bloch; S Wiggins; S Adam; O Suchowersky; M Trew; M Klimek; C R Greenberg; M Eleff; L P Thompson
Journal:  Am J Med Genet       Date:  1992-02-15

6.  Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.

Authors:  M Bloch; S Adam; S Wiggins; M Huggins; M R Hayden
Journal:  Am J Med Genet       Date:  1992-02-15

7.  Attitudes towards predictive testing in Huntington's disease: a recent survey in Belgium.

Authors:  G Evers-Kiebooms; J J Cassiman; H van den Berghe
Journal:  J Med Genet       Date:  1987-05       Impact factor: 6.318

8.  Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.

Authors:  M Bloch; M Fahy; S Fox; M R Hayden
Journal:  Am J Med Genet       Date:  1989-02

9.  Intended use of predictive testing by those at risk for Huntington disease.

Authors:  G J Meissen; R L Berchek
Journal:  Am J Med Genet       Date:  1987-02

10.  Attitudes toward presymptomatic testing in Huntington disease.

Authors:  C Mastromauro; R H Myers; B Berkman
Journal:  Am J Med Genet       Date:  1987-02
View more
  3 in total

1.  Preparing for presymptomatic DNA testing for early onset Alzheimer's disease/cerebral haemorrhage and hereditary Pick disease.

Authors:  A Tibben; M Stevens; G M de Wert; M F Niermeijer; C M van Duijn; J C van Swieten
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

2.  Use of genetic tests among neurologists and psychiatrists: knowledge, attitudes, behaviors, and needs for training.

Authors:  Melissa Salm; Kristopher Abbate; Paul Appelbaum; Ruth Ottman; Wendy Chung; Karen Marder; Cheng-Shiun Leu; Roy Alcalay; Jill Goldman; Alexander Malik Curtis; Christopher Leech; Katherine Johansen Taber; Robert Klitzman
Journal:  J Genet Couns       Date:  2013-06-21       Impact factor: 2.537

3.  Attitudes towards bipolar disorder and predictive genetic testing among patients and providers.

Authors:  L B Smith; B Sapers; V I Reus; N B Freimer
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.